产品详情
文献和实验
相关推荐
COVID-19 Solution
Detection Kit
Instrument
北京卓诚惠生生物科技股份有限公司，是一家专注于为医疗卫生领域病原微生物检测提供解决方案的高新技术企业。公司以多重 PCR 技术为研发技术平台，面向疾病预防控制中心、医院系统研发生产了 400 多种 PCR 检测试剂，包含食源性及消化道感染、发热呼吸道、发热伴出疹、新发及再发传染病检测系列、耐药基因检测、人畜共患病病原体检测等多个系列。为更好地把控质量，我们建成了通过 ISO13485 质量体系与新版 GMP 标准认证的生产车间。产品符合欧盟CE认证标准。公司成立了海外销售事业部，面向亚洲、欧洲、美洲、中东等全球多个国家和地区开展业务。
Beijing Applied Biological Technologies Co., Ltd., a molecular diagnostic enterprise specializing in the development of detection solutions for pathogenic microbes, is headquartered in the Zhongguancun Life Science Park in Beijing. There are two R&D centers and clean workshops that meeting the requirements of MGP, which pass the certification of ISO 13485 quality system. The total number of employees is more than 200, of which 60 are in the R&D team, and more than 60% possess master's degree or above. Our company has been rewarded the third prize of the Science and Technology Award issued by the Beijing Municipal Government and relevant national departments twice. We have successively undertaken four projects from Beijing Municipal Science and Technology Commission, major special projects of national "the 13th Five-year Plan" and other government projects. Encouragingly, the viral nucleic acid detection kits for 2019-nCoV developed in 2020 were selected as a major project of the Beijing Municipal Science and Technology Commission.
Detection Kit
Instrument
北京卓诚惠生生物科技股份有限公司，是一家专注于为医疗卫生领域病原微生物检测提供解决方案的高新技术企业。公司以多重 PCR 技术为研发技术平台，面向疾病预防控制中心、医院系统研发生产了 400 多种 PCR 检测试剂，包含食源性及消化道感染、发热呼吸道、发热伴出疹、新发及再发传染病检测系列、耐药基因检测、人畜共患病病原体检测等多个系列。为更好地把控质量，我们建成了通过 ISO13485 质量体系与新版 GMP 标准认证的生产车间。产品符合欧盟CE认证标准。公司成立了海外销售事业部，面向亚洲、欧洲、美洲、中东等全球多个国家和地区开展业务。
Beijing Applied Biological Technologies Co., Ltd., a molecular diagnostic enterprise specializing in the development of detection solutions for pathogenic microbes, is headquartered in the Zhongguancun Life Science Park in Beijing. There are two R&D centers and clean workshops that meeting the requirements of MGP, which pass the certification of ISO 13485 quality system. The total number of employees is more than 200, of which 60 are in the R&D team, and more than 60% possess master's degree or above. Our company has been rewarded the third prize of the Science and Technology Award issued by the Beijing Municipal Government and relevant national departments twice. We have successively undertaken four projects from Beijing Municipal Science and Technology Commission, major special projects of national "the 13th Five-year Plan" and other government projects. Encouragingly, the viral nucleic acid detection kits for 2019-nCoV developed in 2020 were selected as a major project of the Beijing Municipal Science and Technology Commission.
北京美科美生物技术开发有限公司
代理商实名认证
钻石会员
入驻年限：11年
